ArticleAesthetic plastic surgery2026
Indocyanine Green Angiography Reduces Ischemic Complications in Immediate Implant-Based Breast Reconstruction: A Systematic Review and Meta-analysis.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSkin- and nipple-sparing mastectomy followed by immediate implant-based breast reconstruction (IBBR) has grown substantially in clinical practice, yet mastectomy skin flap necrosis (MSFN) persists as a clinically significant source of morbidity. Intraoperative indocyanine green angiography (ICGA) enables real-time, objective quantification of skin flap perfusion, but its specific effect on IBBR outcomes has yet to be established through dedicated meta-analytic synthesis. This study aimed to evaluate whether intraoperative ICGA-guided decision-making lowers the incidence of MSFN and related surgical complications relative to conventional clinical appraisal in immediate IBBR.
methodsFour databases-PubMed, Embase, Scopus, and the Cochrane Library-were searched through March 2026 for comparative studies of immediate IBBR. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using the Mantel-Haenszel method.
resultsNine studies comprising 1,356 reconstructed breasts (655 ICGA; 701 clinical assessment) met inclusion criteria. ICGA was associated with significantly lower risks of overall MSFN (RR 0.57, 95% CI 0.44-0.73) and severe MSFN (RR 0.35, 95% CI 0.22-0.55), as well as reduced return to the operating room, surgical-site infection, and flap salvage procedures. Overall complication rates, hematoma/seroma, and implant loss were not significantly different between groups.
conclusionsIntraoperative ICGA significantly reduced the risk of overall MSFN by approximately 43% and severe MSFN by approximately 65%, with fewer unplanned reoperations and flap salvage procedures, without affecting non-ischemic outcomes. The evidence supports selective incorporation of ICGA into IBBR surgical protocols, with particular emphasis on patients carrying elevated perfusion-related risk. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine Ratings, please refer to Table of Contents or online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42881300What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.